Development of a Prenatal Test for Fetal Aneuploidy Detection

Status Completed

Clinical Trial Summary

This is an observational study to develop and evaluate a blood based prenatal blood test. Pregnant women confirmed to be carrying a fetus with a chromosomal abnormality will be eligible. Subjects will be asked to provide a blood sample and a limited amount of clinical data that will be recorded on a case report form. All samples and clinical data will be stripped of subject identifiers prior to submission to Ariosa.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01451671
Study type	Observational
Source	Roche Sequencing Solutions
Contact
Status	Completed
Phase
Start date	November 2010
Completion date	November 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04100252` - The Impact of Amniotic Fluid Index (AFI) on Maternal and Perinatal Outcomes in Pregnant Women With Preterm Premature Rupture of Membranes
Recruiting	`NCT04203082` - Cognitive Behavioral Intervention to Reduce Procedural Anxiety Among Woman With High Risk Pregnancies With Scheduled Cesarean Deliveries	N/A
Completed	`NCT02079415` - Infants of Diabetic Mothers: A Cohort Study	N/A
Recruiting	`NCT05678543` - Danish Diabetes Birth Registry 2
Completed	`NCT04158609` - Relationship Between Delivery Route and Fetal Complications With Doppler Indices and CPR Parameters
Recruiting	`NCT04845230` - Fresh RX: NHS 2020	N/A
Recruiting	`NCT06330987` - Fetal Autonomic Nervous sysTem Evaluation
Recruiting	`NCT06405984` - Trans-Abdominal Fetal Pulse Oximetry - EFS-IDE	Early Phase 1